0001958244-24-001074.txt : 20240305
0001958244-24-001074.hdr.sgml : 20240305
20240305171227
ACCESSION NUMBER: 0001958244-24-001074
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 24722203
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: BFI Co., LLC
CENTRAL INDEX KEY: 0001601607
ORGANIZATION NAME:
IRS NUMBER: 262105186
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 2013297300
MAIL ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
144
1
primary_doc.xml
144
0001601607
XXXXXXXX
LIVE
0001069899
Phibro Animal Health Corporation
001-36410
Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21
Teaneck
NJ
07666
1-201-329-7300
BFI Co., LLC
10% Stockholder
Class A Common Stock
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
69080
913928.4
20337574
03/05/2024
NASD
Class A Common Stock
04/14/2014
Private placement from issuer of securities
Phibro Animal Health Corporation
N
21348600
04/14/2014
Exchange of Securities
Y
The sales of shares set forth herein are made in connection with a selling plan dated 6/5/2023 that is intended to comply with Rule 10b5-1(c). The representation below regarding the seller's knowledge of material information was true as of the date the selling plan was entered into.
03/05/2024
06/05/2023
Goldman Sachs & Co. LLC on behalf of Jack Bendheim